doiSerbia

Sexual dimorphism and specificities of psychopharmacological treatment in women

Draganić-Gajić Saveta (Medicinski fakultet, Beograd + Institut za mentalno zdravlje, Beograd)
Lečić-Toševski Dušica (Medicinski fakultet, Beograd + Institut za mentalno zdravlje, Beograd)
Pejović-Milovančević Milica (Medicinski fakultet, Beograd + Institut za mentalno zdravlje, Beograd)
Popović-Deušić Smiljka (Medicinski fakultet, Beograd + Institut za mentalno zdravlje, Beograd)
Gajić Goran (Institut za mentalno zdravlje, Beograd)

The scope of gender related differences observed in mentally ill persons provides a major source of inference about the role of gonadal steroids in brain function and behavior. Reported gender dimorphism in psychiatry includes the following: prevalence of certain mental disorders specific to female gender, phenomenology and treatment characteristics, i.e. response to the applied psychopharmacotherapy. Structural and functional relationship between the hormonal system and central nervous system is closely correlated with vulnerability to various psychopathological disturbances in biologically different stages in women. It has been observed, for instance, that the association of gonadal steroid activity with serotonin is relevant to mood change in premenstrual and postpartum mood disturbances. Gender related hormonal fluctuations may cause or be correlated with the development of several gender-related psychopathological disturbances. The aim of this article is to review the literature concerning gender-related specificities of psychopharmacological treatment of some of the most important mental disorders in women, such as affective disorder in menopause, premenstrual syndrome and postpartum mood disorders.

Keywords: psychopharmacotherapy, sexual dimorphism, mental disorders, women